Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
Kataoka A, Mizumoto C, Kanda J, Iwasaki M, Sakurada M, Oka T, Fujimoto M, Yamamoto Y, Yamashita K, Nannya Y, Ogawa S, Takaori-Kondo A.
Kataoka A, et al. Among authors: yamashita k.
Int J Hematol. 2023 Jun;117(6):919-924. doi: 10.1007/s12185-023-03532-y. Epub 2023 Jan 14.
Int J Hematol. 2023.
PMID: 36641501